Rapid spread of a new West Nile virus lineage 1 associated with increased risk of neuroinvasive disease during a large outbreak in northern Italy, 2022: One Health analysis.

West Nile virus bird fever lineage mosquito neuroinvasive disease

Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
04 Nov 2022
Historique:
received: 08 09 2022
revised: 16 10 2022
entrez: 4 11 2022
pubmed: 5 11 2022
medline: 5 11 2022
Statut: aheadofprint

Résumé

A new strain of WNV lineage 1 (WNV - 1) emerged in the Veneto Region, northern Italy, in 2021, eight years after the last outbreak of WNV - 1 in Italy. The virus, which co-circulates with WNV-2, has become endemic in the Region, where, in 2022, most human cases of neuroinvasive disease (WNND) reported in Europe have occurred. Comparative analysis of the epidemiology and clinical presentation of WNV-1 and WNV-2 infection in humans, as well as the temporal and geographic distribution of WNV-1 and WNV-2 among wild birds and Culex pipiens mosquitoes in Veneto, from May 16th to August 21st, 2022, to determine if the high number of WNND cases was associated with WNV-1. As of August 21st, 2022, 222 human cases of WNV infection were confirmed by molecular testing, including 103 with fever (WNF) and 119 with WNND. WNV lineage was determined in 201 (90.5%) cases, comprising 138 WNV-1 and 63 WNV-2 infections. During the same period, 35 blood donors tested positive, including 30 in whom WNV lineage was determined (13 WNV-1 and 17 WNV-2). Comparative analysis of the distribution of WNV-1 and WNV-2 infections among WNND cases, WNF cases and WNV-positive blood donors showed that patients with WNND were more likely to have WNV-1 infection than blood donors (odds ratio 3.44; 95% CI 95% 1.54 to 8.24; p = 0.0043). As observed in humans, in wild birds WNV-1 had higher infectious rate (IR) and showed a more rapid expansion than WNV-2. At variance, the distribution of the two lineages was more even in mosquitoes, but with a trend of rapid increase of WNV-1 IR over WNV-2. Comparative analysis of WNV-1 vs WNV-2 infection in humans, wild birds, and mosquitos showed a rapid expansion of WNV-1 and suggested that WNV-1 infected patients might have an increased risk to develop severe disease.

Sections du résumé

BACKGROUND BACKGROUND
A new strain of WNV lineage 1 (WNV - 1) emerged in the Veneto Region, northern Italy, in 2021, eight years after the last outbreak of WNV - 1 in Italy. The virus, which co-circulates with WNV-2, has become endemic in the Region, where, in 2022, most human cases of neuroinvasive disease (WNND) reported in Europe have occurred.
METHODS METHODS
Comparative analysis of the epidemiology and clinical presentation of WNV-1 and WNV-2 infection in humans, as well as the temporal and geographic distribution of WNV-1 and WNV-2 among wild birds and Culex pipiens mosquitoes in Veneto, from May 16th to August 21st, 2022, to determine if the high number of WNND cases was associated with WNV-1.
RESULTS RESULTS
As of August 21st, 2022, 222 human cases of WNV infection were confirmed by molecular testing, including 103 with fever (WNF) and 119 with WNND. WNV lineage was determined in 201 (90.5%) cases, comprising 138 WNV-1 and 63 WNV-2 infections. During the same period, 35 blood donors tested positive, including 30 in whom WNV lineage was determined (13 WNV-1 and 17 WNV-2). Comparative analysis of the distribution of WNV-1 and WNV-2 infections among WNND cases, WNF cases and WNV-positive blood donors showed that patients with WNND were more likely to have WNV-1 infection than blood donors (odds ratio 3.44; 95% CI 95% 1.54 to 8.24; p = 0.0043). As observed in humans, in wild birds WNV-1 had higher infectious rate (IR) and showed a more rapid expansion than WNV-2. At variance, the distribution of the two lineages was more even in mosquitoes, but with a trend of rapid increase of WNV-1 IR over WNV-2.
CONCLUSIONS CONCLUSIONS
Comparative analysis of WNV-1 vs WNV-2 infection in humans, wild birds, and mosquitos showed a rapid expansion of WNV-1 and suggested that WNV-1 infected patients might have an increased risk to develop severe disease.

Identifiants

pubmed: 36331269
pii: 6798400
doi: 10.1093/jtm/taac125
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of International Society of Travel Medicine.

Auteurs

Luisa Barzon (L)

Department of Molecular Medicine, University of Padova, via A Gabelli 63, 35121 Padova, Italy.
Microbiology and Virology Unit, Padova University Hospital, via Giustiniani 2, 35128 Padova, Italy.

Monia Pacenti (M)

Microbiology and Virology Unit, Padova University Hospital, via Giustiniani 2, 35128 Padova, Italy.

Fabrizio Montarsi (F)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Diletta Fornasiero (D)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Federica Gobbo (F)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Erika Quaranta (E)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Isabella Monne (I)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Alice Fusaro (A)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Andrea Volpe (A)

Department of Molecular Medicine, University of Padova, via A Gabelli 63, 35121 Padova, Italy.

Alessandro Sinigaglia (A)

Department of Molecular Medicine, University of Padova, via A Gabelli 63, 35121 Padova, Italy.

Silvia Riccetti (S)

Department of Molecular Medicine, University of Padova, via A Gabelli 63, 35121 Padova, Italy.

Emanuela Dal Molin (ED)

Department of Molecular Medicine, University of Padova, via A Gabelli 63, 35121 Padova, Italy.

Sorsha Satto (S)

Microbiology and Virology Unit, Padova University Hospital, via Giustiniani 2, 35128 Padova, Italy.

Vittoria Lisi (V)

Microbiology and Virology Unit, Padova University Hospital, via Giustiniani 2, 35128 Padova, Italy.

Federico Gobbi (F)

Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.

Silvia Galante (S)

UOC Medicina Trasfusionale, ULSS 6 Sede di Camposampiero, Azienda ULSS6 Euganea, via Cosma, 1 - Camposampiero (PD), Italy.

Giuseppe Feltrin (G)

Regional Transplant Centre, Azienda Ospedale Università di Padova, Via Giustiniani 2, 35128 Padova, Italy.

Valerio Valeriano (V)

Dipartimento di Prevenzione - AULSS 6 Euganea; Servizio di Igiene e Sanità Pubblica, UOSD Epidemiologia e Ambiente, Via Ospedale Civile, 22, 35100 - Padova, Italy.

Laura Favero (L)

Direzione Prevenzione, Sicurezza Alimentare, Veterinaria, Regione Veneto, Dorsoduro, 3493 - Rio Novo - 30123 Venezia, Italy.

Francesca Russo (F)

Direzione Prevenzione, Sicurezza Alimentare, Veterinaria, Regione Veneto, Dorsoduro, 3493 - Rio Novo - 30123 Venezia, Italy.

Matteo Mazzucato (M)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Alessio Bortolami (A)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Paolo Mulatti (P)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Calogero Terregino (C)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Gioia Capelli (G)

Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università, 10 - Legnaro (PD), Italy.

Classifications MeSH